<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Cancer[TA]</title><link>http://www.unboundmedicine.com/medline/ebm/journal/Cancer</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Gene expression signature for recurrence in stage III colorectal cancers.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19016304/full_citation/Gene_expression_signature_for_recurrence_in_stage_III_colorectal_cancers_</link><description>Watanabe T, Kobunai T, Sakamoto E, et al. <br/><span class="title">Gene expression signature for recurrence in stage III colorectal cancers. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2008 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19016304/abstract/Gene_expression_signature_for_recurrence_in_stage_III_colorectal_cancers_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19016304/full_citation/Gene_expression_signature_for_recurrence_in_stage_III_colorectal_cancers_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.24023">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19016304/Gene_expression_signature_for_recurrence_in_stage_III_colorectal_cancers_">Find Related Articles</a> </description></item><item><title>The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19016303/full_citation/The_impact_of_positron_emission_tomography__PET__on_expected_management_during_cancer_treatment:_findings_of_the_National_Oncologic_PET_Registry_</link><description>Hillner BE, Siegel BA, Shields AF, et al. <br/><span class="title">The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2008 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19016303/abstract/The_impact_of_positron_emission_tomography__PET__on_expected_management_during_cancer_treatment:_findings_of_the_National_Oncologic_PET_Registry_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19016303/full_citation/The_impact_of_positron_emission_tomography__PET__on_expected_management_during_cancer_treatment:_findings_of_the_National_Oncologic_PET_Registry_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.24000">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19016303/The_impact_of_positron_emission_tomography__PET__on_expected_management_during_cancer_treatment:_findings_of_the_National_Oncologic_PET_Registry_">Find Related Articles</a> </description></item><item><title>Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19016301/full_citation/Comparison_of_ProEx_C_with_p16INK4a_and_Ki_67_immunohistochemical_staining_of_cell_blocks_prepared_from_residual_liquid_based_cervicovaginal_material:_a_pilot_study_</link><description>Halloush RA, Akpolat I, Jim Zhai Q, et al. <br/><span class="title">Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2008 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19016301/abstract/Comparison_of_ProEx_C_with_p16INK4a_and_Ki_67_immunohistochemical_staining_of_cell_blocks_prepared_from_residual_liquid_based_cervicovaginal_material:_a_pilot_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19016301/full_citation/Comparison_of_ProEx_C_with_p16INK4a_and_Ki_67_immunohistochemical_staining_of_cell_blocks_prepared_from_residual_liquid_based_cervicovaginal_material:_a_pilot_study_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.23951">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19016301/Comparison_of_ProEx_C_with_p16INK4a_and_Ki_67_immunohistochemical_staining_of_cell_blocks_prepared_from_residual_liquid_based_cervicovaginal_material:_a_pilot_study_">Find Related Articles</a> </description></item><item><title>Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19016270/full_citation/Psychologic_intervention_improves_survival_for_breast_cancer_patients:_a_randomized_clinical_trial_</link><description>Andersen BL, Yang HC, Farrar WB, et al. <br/><span class="title">Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer">Cancer 2008 Nov 17.:3450-3458.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19016270/abstract/Psychologic_intervention_improves_survival_for_breast_cancer_patients:_a_randomized_clinical_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19016270/full_citation/Psychologic_intervention_improves_survival_for_breast_cancer_patients:_a_randomized_clinical_trial_">Full Citation</a> | <a href="http://dx.doi.org/10.1002/cncr.23969">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19016270/Psychologic_intervention_improves_survival_for_breast_cancer_patients:_a_randomized_clinical_trial_">Find Related Articles</a> </description></item><item><title>Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014680/full_citation/Activation_of_MEK1_or_MEK2_isoform_is_sufficient_to_fully_transform_intestinal_epithelial_cells_and_induce_the_formation_of_metastatic_tumors_</link><description>Voisin L, Julien C, Duhamel S, et al. <br/><span class="title">Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2008 Nov 17; 8(1):337.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014680/abstract/Activation_of_MEK1_or_MEK2_isoform_is_sufficient_to_fully_transform_intestinal_epithelial_cells_and_induce_the_formation_of_metastatic_tumors_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014680/full_citation/Activation_of_MEK1_or_MEK2_isoform_is_sufficient_to_fully_transform_intestinal_epithelial_cells_and_induce_the_formation_of_metastatic_tumors_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19014680/Activation_of_MEK1_or_MEK2_isoform_is_sufficient_to_fully_transform_intestinal_epithelial_cells_and_induce_the_formation_of_metastatic_tumors_">Find Related Articles</a> </description></item><item><title>Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014679/full_citation/Dissemination_of_periodic_mammography_and_patterns_of_use_by_birth_cohort_in_Catalonia__Spain__</link><description>Rue M, Carles M, Vilaprinyo E, et al. <br/><span class="title">Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain). [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2008 Nov 17; 8(1):336.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014679/abstract/Dissemination_of_periodic_mammography_and_patterns_of_use_by_birth_cohort_in_Catalonia__Spain__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014679/full_citation/Dissemination_of_periodic_mammography_and_patterns_of_use_by_birth_cohort_in_Catalonia__Spain__">Full Citation</a></description></item><item><title>Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014607/full_citation/Prognostic_significance_of_Hypoxia_Inducible_Factor_1_alpha_HIF_1alpha__expression_in_serous_ovarian_cancer:_an_immunohistochemical_study_</link><description>Daponte A, Ioannou M, Mylonis I, et al. <br/><span class="title">Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2008 Nov 16; 8(1):335.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014607/abstract/Prognostic_significance_of_Hypoxia_Inducible_Factor_1_alpha_HIF_1alpha__expression_in_serous_ovarian_cancer:_an_immunohistochemical_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014607/full_citation/Prognostic_significance_of_Hypoxia_Inducible_Factor_1_alpha_HIF_1alpha__expression_in_serous_ovarian_cancer:_an_immunohistochemical_study_">Full Citation</a></description></item><item><title>Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014602/full_citation/Elevation_of_circulating_big_endothelin_1:_an_independent_prognostic_factor_for_tumor_recurrence_and_survival_in_patients_with_esophageal_squamous_cell_carcinoma_</link><description>Jiao W, Xu J, Zheng J, et al. <br/><span class="title">Elevation of circulating big endothelin-1: an independent prognostic factor for tumor recurrence and survival in patients with esophageal squamous cell carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2008 Nov 15; 8(1):334.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014602/abstract/Elevation_of_circulating_big_endothelin_1:_an_independent_prognostic_factor_for_tumor_recurrence_and_survival_in_patients_with_esophageal_squamous_cell_carcinoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014602/full_citation/Elevation_of_circulating_big_endothelin_1:_an_independent_prognostic_factor_for_tumor_recurrence_and_survival_in_patients_with_esophageal_squamous_cell_carcinoma_">Full Citation</a></description></item><item><title>Deoxycholic Acid Induces MUC2 Intestinal Mucin Overexpression via NF-kappaB Through PKC in Human Esophageal Adenocarcinoma Cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014523/full_citation/Deoxycholic_Acid_Induces_MUC2_Intestinal_Mucin_Overexpression_via_NF_kappaB_Through_PKC_in_Human_Esophageal_Adenocarcinoma_Cells_</link><description>Wu J, Gong J, Geng J, et al. <br/><span class="title">Deoxycholic Acid Induces MUC2 Intestinal Mucin Overexpression via NF-kappaB Through PKC in Human Esophageal Adenocarcinoma Cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2008 Nov 13; 8(1):333.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014523/abstract/Deoxycholic_Acid_Induces_MUC2_Intestinal_Mucin_Overexpression_via_NF_kappaB_Through_PKC_in_Human_Esophageal_Adenocarcinoma_Cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014523/full_citation/Deoxycholic_Acid_Induces_MUC2_Intestinal_Mucin_Overexpression_via_NF_kappaB_Through_PKC_in_Human_Esophageal_Adenocarcinoma_Cells_">Full Citation</a></description></item><item><title>XM02 is superior to placebo and equivalent to NeupogenTM in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19014494/full_citation/XM02_is_superior_to_placebo_and_equivalent_to_NeupogenTM_in_reducing_the_duration_of_severe_neutropenia_and_the_incidence_of_febrile_neutropenia_in_cycle_1_in_breast_cancer_patients_receiving_docetaxel/doxorubicin_chemotherapy_</link><description>Del Giglio A, Eniu A, Ganea-Motan D, et al. <br/><span class="title">XM02 is superior to placebo and equivalent to NeupogenTM in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC cancer">BMC Cancer 2008 Nov 12; 8(1):332.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19014494/abstract/XM02_is_superior_to_placebo_and_equivalent_to_NeupogenTM_in_reducing_the_duration_of_severe_neutropenia_and_the_incidence_of_febrile_neutropenia_in_cycle_1_in_breast_cancer_patients_receiving_docetaxel/doxorubicin_chemotherapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19014494/full_citation/XM02_is_superior_to_placebo_and_equivalent_to_NeupogenTM_in_reducing_the_duration_of_severe_neutropenia_and_the_incidence_of_febrile_neutropenia_in_cycle_1_in_breast_cancer_patients_receiving_docetaxel/doxorubicin_chemotherapy_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19014494/XM02_is_superior_to_placebo_and_equivalent_to_NeupogenTM_in_reducing_the_duration_of_severe_neutropenia_and_the_incidence_of_febrile_neutropenia_in_cycle_1_in_breast_cancer_patients_receiving_docetaxel/doxorubicin_chemotherapy_">Find Related Articles</a> </description></item></channel></rss>